SciPharm SARL
🇱🇺Luxembourg
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
2
EMA:2
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
Phase 3
Completed
- Conditions
- Non-operable Chronic Thromboembolic Pulmonary Hypertension
- Interventions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- SciPharm SàRL
- Target Recruit Count
- 105
- Registration Number
- NCT01416636
- Locations
- 🇦🇹
Krankenhaus der Elisabethinen, Linz, Austria
🇦🇹Medical University of Vienna AKH - Division Cardiology, Vienna, Austria
🇨🇿II. interní klinika Všeobecná fakultní nemocnice, Prague, Czechia
News
No news found